Name of bioresource/bank
Cambridge Brain Bank (CBB)
Name of Principal Investigator
| Title | Peter |
| First name | Collins |
| Last name | Professor |
Address of institution where award is held
| Institution | Addenbrookes Hospital,Histopathology , Box 235 |
| Street Address | Hills Road |
| City | Cambridge |
| Postcode | CB2 0QQ |
Country
United Kingdom
Website
www.cuh.org.uk/research/public/public_index.html
Contact email (e.g. manager or coordinator)
Funding source
NIHR Cambridge Biomedical Research Centre
Q1 What conditions does your resource cover?
Alzheimer’s disease and other dementias Motor neurone diseases Parkinson’s disease Motor neurone diseases Prion disease Huntington’s disease Spinocerebellar ataxia (SCA) Spinal muscular atrophy (SMA) Neurodegenerative disease in general Parkinson’s disease
Q2a What DNA collection does your resources hold?
1-100 donors
Q2b What cell lines does your resource hold?
None
Q2c What tissue (including post-mortem tissue) does your resource hold?
1001-5000 donors
Q3 Are human tissues/samples/DNA from
Post-mortem donors: other (specify) Post-mortem donors: brain Post-mortem donors: spinal cord
Q4 Are tissues/samples/DNA from
Healthy individuals/control donors Patients
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
In a specific study-associated dataset Collected as part of a specific clinical trial(s)
Q6 In what form are samples supplied?
Primary samples: Supplied fresh Primary Samples: Stabilised samples (frozen or fixed) Secondary samples:(derivatives of primary samples) Secondary samples: plasma Secondary samples: RNA Secondary samples: protein extracts Secondary samples: cell lines derived from primary samples
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
No
Q8 What is the status of your tissue/sample/DNA collection?
Collection ongoing
Q9 What are the rules and procedures for access?
Access Committee mechanism Local/ regional access National access International access Access to industry Access for pilot studies permitted Applicant needs to provide separate external ethics approval